Mark T.A. Donoghue

12.9k total citations · 2 hit papers
58 papers, 3.1k citations indexed

About

Mark T.A. Donoghue is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark T.A. Donoghue has authored 58 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Mark T.A. Donoghue's work include Cancer Genomics and Diagnostics (17 papers), Plant nutrient uptake and metabolism (9 papers) and Plant Molecular Biology Research (8 papers). Mark T.A. Donoghue is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Plant nutrient uptake and metabolism (9 papers) and Plant Molecular Biology Research (8 papers). Mark T.A. Donoghue collaborates with scholars based in United States, Ireland and Canada. Mark T.A. Donoghue's co-authors include Charles Spillane, S. Duygu Selçuklu, Robert A. Martienssen, Barry S. Taylor, Filipe Borges, Frédéric Van Ex, Rui Gardner, Joseph P. Calarco, Frédéric Berger and Pauline E. Jullien and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Mark T.A. Donoghue

54 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reprogramming of DNA Methylation in Pollen Guides Epigenetic Inheritance via Small RNA

2012 417 citations Mark T.A. Donoghue, Robert A. Martienssen et al. profile →
Genome doubling shapes the evolution and prognosis of advanced cancers

2018 343 citations Craig M. Bielski, Ahmet Zehir et al. Nature Genetics profile →

Peers

Mark T.A. Donoghue

ONCOL

PRM

Harmen J.G. van de Werken Netherlands

Sebastian Bender Germany

Tobias Grob Germany

Adam J. Dupuy United States

Bernat Gel Spain

Vincent Schulz United States

Anton Krumm United States

Joanna C. Fowler Australia

Yasushi Totoki Japan

J. N. Lucas United States

Harmen J.G. van de Werken Netherlands

Mark T.A. Donoghue

3.4k ×1.9

577 ×0.5

851 ×0.9

627 ×1.1

ONCOL

232 ×0.5

PRM

Citations per year, relative to Mark T.A. Donoghue Mark T.A. Donoghue (= 1×) peers Harmen J.G. van de Werken

Countries citing papers authored by Mark T.A. Donoghue

Since Specialization

Citations

This map shows the geographic impact of Mark T.A. Donoghue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T.A. Donoghue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T.A. Donoghue more than expected).

Fields of papers citing papers by Mark T.A. Donoghue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T.A. Donoghue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T.A. Donoghue. The network helps show where Mark T.A. Donoghue may publish in the future.

Co-authorship network of co-authors of Mark T.A. Donoghue

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T.A. Donoghue. A scholar is included among the top collaborators of Mark T.A. Donoghue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T.A. Donoghue. Mark T.A. Donoghue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilcox, James A., Glenn Heller, Noura J. Choudhury, et al.. (2025). Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases. Annals of Oncology. 36(10). 1142–1153.

Lin, Andrew, Vasilisa A. Rudneva, Nazanin Majd, et al.. (2025). Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 110(11). 3066–3073. 5 indexed citations

Walmsley, Charlotte S., Philip Jonsson, Michael L. Cheng, et al.. (2024). Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy. npj Precision Oncology. 8(1). 34–34. 7 indexed citations

Rosenbaum, Evan, Kenneth Seier, Martina Bradić, et al.. (2023). Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Research Communications. 3(10). 2118–2125. 6 indexed citations

Bhattarai, Tripti Shrestha, Tambudzai Shamu, Alexander N. Gorelick, et al.. (2022). AKT mutant allele-specific activation dictates pharmacologic sensitivities. Nature Communications. 13(1). 2111–2111. 26 indexed citations

Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome. Clinical Cancer Research. 26(20). 5448–5455. 12 indexed citations

Hensley, Martee L., Shweta S. Chavan, David B. Solit, et al.. (2020). Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clinical Cancer Research. 26(14). 3881–3888. 67 indexed citations

McIntyre, Caitlin A., Sharon Lawrence, Allison L. Richards, et al.. (2020). Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. Cancer. 126(17). 3939–3949. 49 indexed citations

Paik, Paul K., Rachel K. Kim, Linda S. Ahn, et al.. (2020). A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers. Clinical Cancer Research. 26(8). 1796–1802. 10 indexed citations

10.

Lin, Andrew, Mark T.A. Donoghue, Sharon L. Wardlaw, et al.. (2020). Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor. The Journal of Clinical Endocrinology & Metabolism. 105(12). 3807–3820. 15 indexed citations

11.

Schoenfeld, Adam J., Joseph Montecalvo, Azadeh Namakydoust, et al.. (2020). A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer. Journal of Thoracic Oncology. 15(2). S14–S14. 1 indexed citations

12.

Bandlamudi, Chai, Jennifer L. Sauter, William D. Travis, et al.. (2020). Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas. Annals of Oncology. 31(5). 599–608. 219 indexed citations

13.

Vilhjálmsson, Bjarni J., Thomas Juenger, Mark T.A. Donoghue, et al.. (2019). Transgenerational effects of inter-ploidy cross direction on reproduction and F2 seed development of Arabidopsis thaliana F1 hybrid triploids. Plant Reproduction. 32(3). 275–289. 6 indexed citations

14.

Ferreira, Liliana J., Mark T.A. Donoghue, Pedro M. Barros, et al.. (2019). Uncovering Differentially Methylated Regions (DMRs) in a Salt-Tolerant Rice Variety under Stress: One Step towards New Regulatory Regions for Enhanced Salt Tolerance. Epigenomes. 3(1). 4–4. 19 indexed citations

15.

Bielski, Craig M., Ahmet Zehir, Alexander Penson, et al.. (2018). Genome doubling shapes the evolution and prognosis of advanced cancers. Nature Genetics. 50(8). 1189–1195. 343 indexed citations breakdown →

16.

Park, Stephen D. E., David A. Magee, Paul McGettigan, et al.. (2015). Genome sequencing of the extinct Eurasian wild aurochs, Bos primigenius, illuminates the phylogeography and evolution of cattle. Genome biology. 16(1). 234–234. 115 indexed citations

17.

Jacob, Yannick, Elisa Bergamin, Mark T.A. Donoghue, et al.. (2014). Selective Methylation of Histone H3 Variant H3.1 Regulates Heterochromatin Replication. Science. 343(6176). 1249–1253. 145 indexed citations

18.

Selçuklu, S. Duygu, Mark T.A. Donoghue, Ayşegül Sapmaz, et al.. (2014). ALCAM is indirectly modulated by miR-125b in MCF7 cells. Tumor Biology. 36(5). 3511–3520. 5 indexed citations

19.

O’Connell, Mary J., Aisling Doyle, Thomas Juenger, et al.. (2012). In Arabidopsis thaliana codon volatility scores reflect GC3 composition rather than selective pressure. BMC Research Notes. 5(1). 359–359. 3 indexed citations

20.

Selçuklu, S. Duygu, Mark T.A. Donoghue, Kristina Rehmet, et al.. (2012). MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells. Journal of Biological Chemistry. 287(35). 29516–29528. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact